In a large study of postmenopausal women, those who had ever taken a short-acting calcium channel blocker (CCB) saw their pancreatic cancer risk shoot up by 66 percent.
From: https://www.webmd.com/cancer/pancreatic-cancer/news/20180417/bp-meds-tied-to-pancreatic-cancer-risk-in-women?src=RSS_PUBLIC
No comments:
Post a Comment